• 2023.0306

    The Development of Reporting Guideline of clinical Practice Guidelines in General Practice provides detailed guidance for the makers and writers of the general practice guidelines, which will further improve the reporting quality of the general practice guidelines, especially the Chinese general practice guidelines, and promote the application in general medical practice, thus finally improving the quality of primary medical care.

  • 2023.0220

    Professor Gordon Guyatt of McMaster University and Professor Victor Montori of the Mayo Clinic jointly published a paper in the British Medical Journal (BMJ) entitled: Guidelines should consider clinicians' time needed to treat on January 3, 2023.

  • 2022.1126

    IGEST is a generic tool for screening guidelines for any specialty, target population, and healthcare organization, but it is intended only as a screening tool, primarily for quickly assessing guideline quality and determining whether they can be adopted or adapted in other settings, and is not a substitute for some of the more complex guideline quality evaluation tools.

  • 2022.1031

    In July 2022, Jose F. Meneses-Echavez et al. from the Norwegian Institute of Public Health published an article in the Journal of Clinical Epidemiology entitled "Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations". The aim of this study was to identify and describe the processes suggested for the formulation of healthcare recommendations in healthcare guidelines available in guidance documents.

Register MORE
  • 2024.0723
    Successful international tobacco control experience shows that the help provided by doctors to quit smoking plays an important role in reducing the smoking rate of the population. However, clinicians in our country lack the time and skills to implement smoking cessation interventions, and the resources of professional smoking cessation services are limited in most regions, which makes it difficult for smokers in our country to obtain professional smoking cessation services. With the maturity of digital health technologies (DHT), a variety of DHT technologies in the field of smoking cessation have appeared and have shown positive results. Due to its convenience and no geographical restrictions, it is expected to alleviate the shortage of traditional smoking cessation services. However, there is still a lack of clinical practice guidelines to guide the application of smoking cessation DHT technologies, making it difficult for such technologies to play a practical role. The "Chines Application Guideline for Digital Health Technologies on Smoking cessation" aims to establish a digital smoking cessation intervention paradigm. This will help promote the development and application of digital smoking cessation technologies in China, and promote the diversification and accessibility of smoking cessation services in China.
  • 2024.0723
    Placental transfusion is an operation that has important and widespread benefits for newborns, and also has no threat to the mothers’ health. It is an initiative that is easy to promote. Special conditions in obstetrics, such as neonatal perinatal hypoxia, fetal growth restriction, neonatal erythrocyte homoimmunity, neonatal congenital heart disease, twin pregnancy, maternal HIV positive, umbilical cord blood gas specimen and umbilical cord blood bank collection, often affect clinical decisions of neonatologists. In 2021, the expert consensus on the application of placental transfusion in newborns with special obstetric conditions was issued, and in the past three years, new research progress has been made on these issues. Therefore, the expert group plans to develop updated guidelines based on high-quality evidence, standardized clinical practice, and broad consensus to promote the use of placental transfusion in perinatal medicine in China.
  • 2024.0723
    Rheumatoid arthritis (RA) is an autoimmune disease characterized by multiple symmetrical small joints. The exact etiology and pathogenesis of RA have not yet been fully elucidated. The typical pathology of arthropathy is synovitis, which progressively destroys articular cartilage and bone, eventually leading to joint deformity and loss of function. The risk of disability and functional limitation in RA patients increases with the duration of the disease. In addition to joint lesions, RA can also cause lesions in the lungs, cardiovascular system, eyes and blood system of almost all systems of the body, and some RA is also prone to complications such as malignant tumors and depression. In summary, it can be seen that RA has brought a huge economic and social burden to the creation of a harmonious society in China. Therefore, strengthening the research and prevention of RA has become a very urgent task and challenge for China. Therefore, this project aims to standardize the RA hierarchical diagnosis and treatment norms, provide standardized management strategies and methods for general practitioners, and comprehensively improve the referral level of RA.
  • 2024.0723
    Pain is one of the most common symptoms in cancer patients and a major factor severely affecting their quality of life. The treatment of cancer pain involves various aspects including oncology, radiation therapy, minimally invasive interventions, traditional Chinese medicine, psychosocial support, anesthesia, and rehabilitation therapy. This consensus provides guidance for the comprehensive multidisciplinary management and treatment of cancer pain, aiming to promote the development of individualized and standardized diagnosis and treatment of cancer pain
  • 2024.0722
    Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease with aggressive, symmetric polyarthritis as the main clinical manifestation. It is a major and difficult disease in rheumatism. The etiology is complex, and it is related to many factors such as genetics, environment, sex hormones and so on. The global prevalence of RA is 0.5% - 1%, and the prevalence in mainland China is 0.28% - 0.4%. The prevalence ratio of men and women is about 1:4. The disability rate of RA in 5-10 years is 60%, and the disability rate of RA in 30 years is more than 90%. A variety of complications such as heart disease, interstitial lung disease, osteoporosis, etc. are common, which seriously affect the labor force and quality of life of patients, and bring heavy economic burden to patients' families and society. It is of great significance for human health to explore and sort out RA diagnosis and treatment methods from multiple angles. According to Mongolian medicine, people suffer from diseases because of abnormal changes in internal factors such as Heyi, Sheila, badakan, Qisu (blood), Sheila Wusu (yellow water), sticky or Haori damage (insects). Due to the influence of diet, daily life, season and other factors, any one or several of the above factors lose the normal state and the balance between each other, causing damage to human tissues and organs and resulting in disease. Mongolian medicine treatment of the disease is based on the principles of dryness, xieriwusu, clearing blood heat and syndrome differentiation. The recommended drugs are Elji genchus-25, senden-23, Chagan gugul-10, garidi-5, Saren Garidi, etc. However, at present, no standardized diagnosis and treatment scheme has been established for the prevention and treatment of tulai disease (rheumatoid arthritis) by Mongolian medicine, which is difficult to be recognized and applied in clinical practice. In recent years, many international academic organizations in the field of Rheumatology have formulated or revised their own RA diagnosis and treatment guidelines, and China has also formulated relevant guidelines in combination with the national conditions and the actual situation of RA diagnosis and treatment. Mongolian medicine, as an important part of ethnic medicine, has certain advantages in the treatment of rheumatoid arthritis. It has accumulated rich clinical experience in the treatment of the disease, and has formed some unique therapies. Most of them are adapted to local conditions, select genuine medicinal materials, have little toxic and side effects, and are simple and inexpensive. Commonly used therapies include oral administration or oral administration combined with acupuncture, fumigation, blood pricking cupping, and fire therapy, which are very effective in improving symptoms and improving clinical efficacy. Although Mongolian medicine has certain advantages in the prevention and treatment of rheumatoid arthritis, and has a unique and complete understanding of it, it has not yet formed a standardized guide or recommendation or expert consensus, which is difficult to be recognized and applied in clinical practice. This consensus is committed to fully explore and give full play to the unique advantages of Mongolian medicine in the treatment of rheumatoid arthritis, aiming to provide clinicians with scientific and practical treatment suggestions to guide their clinical decision-making, so as to improve the prognosis and quality of life of patients. At the same time, it will help to enhance the influence and recognition of Mongolian medicine in the academic community.
Registration process and operational mode of a CPG registry